Research Overview of Ovigil 5000IU Sanzyme
Ovigil 5000IU Sanzyme is a gonadotropin hormone preparation containing human chorionic gonadotropin (hCG) manufactured by Sanzyme for laboratory research applications. This injectable solution provides researchers at Stroid UK Shop with a standardised 5000 international unit formulation to investigate hormonal regulation pathways and endocrine system recovery mechanisms. The compound represents a critical research tool for scientists examining luteinising hormone mimetic properties and their effects on gonadal function in controlled laboratory environments.
Laboratory Research Applications
Research scientists utilise Ovigil 5000IU to investigate post-cycle recovery protocols within gonadotropin post cycle therapy studies. The compound allows examination of hypothalamic-pituitary-gonadal axis restoration following experimental interventions. Researchers can analyse how hCG supplementation influences natural hormone production recovery timelines, comparing outcomes against other research compounds from our SARMs collection. Laboratory studies frequently incorporate this gonadotropin alongside investigations using peptides to understand comprehensive hormonal recovery mechanisms. The injectable format enables precise dosimetric control for experimental protocols requiring consistent bioavailability profiles.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Human Chorionic Gonadotropin |
| Strength | 5000 International Units |
| Manufacturer | Sanzyme Limited |
| Form | Injectable Solution |
| Storage | 2-8°C Refrigerated |
| Molecular Weight | Verify with supplier |
| CAS Number | Verify with supplier |
| Solubility | Water Soluble |
Research Compliance Statement
Ovigil 5000IU Sanzyme is supplied exclusively for in-vitro laboratory research purposes and is not intended for human consumption or therapeutic use. Researchers must ensure proper storage conditions and handling protocols are maintained throughout their investigations. All experimental procedures should comply with institutional research guidelines and appropriate biosafety measures when examining this gonadotropin compound.
